This video was recorded at the ESC in Paris, France, on September 2, 2019.
Dr Michael Maeng of Aarhus University Hospital and Aarhus University.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
ESC 2019 Long-term follow-up data of the DANAMI-2 trial showed that pPCI is the best strategy for STEMI patients compared to fibrinolysis, if transport to an invasive center is less than two hours.